Telos Capital Management Inc. Purchases Shares of 4,451 VanEck Pharmaceutical ETF (NASDAQ:PPH)

Telos Capital Management Inc. acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 4,451 shares of the company’s stock, valued at approximately $384,000.

A number of other hedge funds have also modified their holdings of PPH. FMR LLC raised its holdings in shares of VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after acquiring an additional 212 shares during the period. Edge Financial Advisors LLC purchased a new position in VanEck Pharmaceutical ETF during the 3rd quarter worth approximately $263,000. Grimes & Company Inc. acquired a new stake in VanEck Pharmaceutical ETF during the 4th quarter valued at $310,000. Elm3 Financial Group LLC purchased a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $324,000. Finally, Harbour Investments Inc. boosted its position in shares of VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after buying an additional 488 shares during the period.

VanEck Pharmaceutical ETF Trading Down 0.4 %

Shares of PPH stock opened at $89.40 on Friday. The company has a market capitalization of $557.86 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1-year low of $84.48 and a 1-year high of $99.51. The stock’s fifty day simple moving average is $87.76 and its 200-day simple moving average is $91.73.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were paid a dividend of $0.411 per share. The ex-dividend date was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.